ImaginAb Secures $21,000,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b813c4c-5c6b-4b40-b795-5918de6b7f89
Date
5/9/2014
Company Name
ImaginAb
Mailing Address
423 Hindry Ave. Inglewood, CA 90301 USA
Company Description
ImaginAb’s mission is to transform the clinical management of cancer and autoimmune diseases via targeted molecular imaging. We re-engineer therapeutic antibodies against biologically important targets into small proteins optimized for diagnostic imaging with Positron Emission Tomography (PET).
Website
http://www.imaginab.com
Transaction Type
Venture Equity
Transaction Amount
$21,000,000
Transaction Round
Series B
Proceeds Purposes
We have made excellent progress with our programs in cancer and immunology, and we are pleased to have concluded this round of growth capital to accelerate the development of IAB2M, our lead program in prostate cancer, and continue to expand our product pipeline.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor